Detection of <i>Aeromonas</i>, <i>Campylobacter</i> and <i>Salmonella</i> using concurrent bacterial culture and commercial multiplex PCR, Sydney, Australia, 2023. [PDF]
Yuwono C +4 more
europepmc +1 more source
Consequences of <i>Campylobacter jejuni</i> and <i>Campylobacter coli</i> Colonisation of Piglets on Gut Microbiota and Microbial Metabolites. [PDF]
Rath A +8 more
europepmc +1 more source
The synergistic action of reduced membrane permeability and antibiotic sequestration as a novel mechanism for carbapenem resistance in <i>Campylobacter</i>. [PDF]
Chen X +15 more
europepmc +1 more source
Triple Infections With Campylobacter coli, Cytomegalovirus, and SARS-CoV-2 in a Lymphoma Patient Treated With Epcoritamab. [PDF]
Imataki O, Takagi H, Ishida T, Uemura M.
europepmc +1 more source
Ivermectin Treatment for <i>Strongyloides stercoralis-</i>Associated Recurrence of Nongastric MALT Lymphoma. [PDF]
Misirian A, Quon CM, Maranzano M, Tam E.
europepmc +1 more source
A review of chronic enterocolitis of rhesus macaques (<i>Macaca mulatta</i>) and potential as a naturally occurring model for post-infectious irritable bowel syndrome. [PDF]
Bacon RL, Lawhon SD, Gray SB, Hodo CL.
europepmc +1 more source
Sequential infections of <i>Campylobacter jejuni</i> and <i>Salmonella gastroenteritis</i> complicated by myocarditis: a case report. [PDF]
AlGhawi RJ +3 more
europepmc +1 more source
Related searches:
To the Editor.— Chamovitz et al1 recently reported the occurrence of hemolytic-uremia syndrome with evidence of Campylobacter jejuni infection in both a mother and daughter. Although they indicated that there were no previous reports of the association of this enteric pathogen with hemolytic-uremic syndrome, we must point out the report ...
S T, Shulman, D, Moel
openaire +2 more sources
Campylobacter fetus infections
Médecine et Maladies Infectieuses, 2014Campylobacter fetus infections usually occur in immunodepressed patients or patients presenting with diabetes mellitus or cancer. They rarely cause diarrhea but frequently cause bacteremia or vascular diseases. The therapeutic management is not well codified and fluoroquinolone resistance is continuously increasing.We conducted a retrospective study of
A, Cypierre +7 more
openaire +2 more sources

